PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

The use of anticoagulants for prevention and treatment of osteonecrosis of the femoral head: A systematic review.

Abstract Osteonecrosis of the femoral head (ONFH) is a progressive disease, which mainly affects young adults and often necessitates total hip arthroplasty (THA), so early interventions are critical to successfully protect hip joint from THA. In this review, our purpose was to determine the effects of anticoagulants for preventing and treating the primary and secondary ONFH, respectively, before the collapse stage or before the pathology of necrosis.
PMID
Related Publications

Early Outcomes of Primary Total Hip Arthroplasty for Osteonecrosis of the Femoral Head in Patients with Human Immunodeficiency Virus in China.

EFFECTIVENESS OF BONE GRAFTING THROUGH WINDOWING AT FEMORAL HEAD-NECK JUNCTION FOR TREATMENT OF OSTEONECROSIS WITH SEGMENTAL COLLAPSE OF FEMORAL HEAD.

The use of bisphosphonate in the treatment of osteonecrosis of the femoral head: a meta-analysis of randomized control trials.

Difference in periprosthetic acetabular bone mineral density: Prior total hip arthroplasty: Osteonecrosis of the femoral head versus primary osteoarthritis.

The efficacy of targeted intraarterial delivery of concentrated autologous bone marrow containing mononuclear cells in the treatment of osteonecrosis of the femoral head: a five year follow-up study.

Authors

Mayor MeshTerms
Keywords
Journal Title medicine
Publication Year Start




PMID- 28422866
OWN - NLM
STAT- In-Process
DA  - 20170419
LR  - 20170429
IS  - 1536-5964 (Electronic)
IS  - 0025-7974 (Linking)
VI  - 96
IP  - 16
DP  - 2017 Apr
TI  - The use of anticoagulants for prevention and treatment of osteonecrosis of the
      femoral head: A systematic review.
PG  - e6646
LID - 10.1097/MD.0000000000006646 [doi]
AB  - BACKGROUND: Osteonecrosis of the femoral head (ONFH) is a progressive disease,
      which mainly affects young adults and often necessitates total hip arthroplasty
      (THA), so early interventions are critical to successfully protect hip joint from
      THA. In this review, our purpose was to determine the effects of anticoagulants
      for preventing and treating the primary and secondary ONFH, respectively, before 
      the collapse stage or before the pathology of necrosis. METHODS: We searched
      PubMed, Embase, Web of Science databases for relevant studies. Any observational 
      or experimental studies that evaluated anticoagulants and ONFH were our goal of
      searching the electric databases. RESULTS: Four studies including a total of 218 
      hips were identified in this review, 2 of them were prospective studies which
      performed by 1 group, 1 was a retrospective study, and the last was a prospective
      comparative study. CONCLUSIONS: Our findings supported that the anticoagulants
      could be used for primary ONFH. However, anticoagulants cannot play a protective 
      role on secondary ONFH. Moreover, there were no serious adverse effects reported 
      in the studies after anticoagulants treatment. Nevertheless, our present study
      with some limitations such as the limited sample size only provided limited
      quality of evidence; confirmation from further systematic review or meta-analysis
      with large-scale, well-designed randomized control trials is required.
FAU - Guo, Peipei
AU  - Guo P
AD  - aPlastic Surgery Hospital, Chinese Academy of Medical Sciences, The graduate
      school of Peking Union Medical College bCentre for Osteonecrosis and
      Joint-Preserving & Reconstruction, Department of Orthopedic Surgery, Beijing Key 
      Laboratory of Arthritic and Rheumatic Diseases, China-Japan Friendship Hospital, 
      National Health and Family Planning Commission of the People's Republic of China 
      cDepartment of Trauma and Orthopedics, Peking University People's Hospital,
      Beijing, China dDepartment of Internal Medicine, Shandong Shouguang People's
      Hospital, Shandong Province, China.
FAU - Gao, Fuqiang
AU  - Gao F
FAU - Wang, Yanhua
AU  - Wang Y
FAU - Zhang, Zhenkun
AU  - Zhang Z
FAU - Sun, Wei
AU  - Sun W
FAU - Jiang, Baoguo
AU  - Jiang B
FAU - Wang, Bailiang
AU  - Wang B
FAU - Li, Zirong
AU  - Li Z
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Medicine (Baltimore)
JT  - Medicine
JID - 2985248R
PMC - PMC5406082
EDAT- 2017/04/20 06:00
MHDA- 2017/04/20 06:00
CRDT- 2017/04/20 06:00
AID - 10.1097/MD.0000000000006646 [doi]
AID - 00005792-201704210-00047 [pii]
PST - ppublish
SO  - Medicine (Baltimore). 2017 Apr;96(16):e6646. doi: 10.1097/MD.0000000000006646.

<?xml version="1.0" encoding="UTF-8"?>
<b:Sources SelectedStyle="" xmlns:b="http://schemas.openxmlformats.org/officeDocument/2006/bibliography"  xmlns="http://schemas.openxmlformats.org/officeDocument/2006/bibliography" >
</b:Sources>